271578-75-7

Upstream product

• 351379-36-7 (2S,3S)-3-Azido-4-[2-(tert-butyl-dimethyl-silanyloxymethyl)-3,4,6-trimethoxy-5-methyl-phenyl]-butane-1,2-diol 
• 271578-69-9 2,2-dimethyl-propionic acid 4-[2-(tert-butyl-dimethyl-silanyloxymethyl)-3,4,6-trimethoxy-5-methyl-phenyl]-but-2-enyl ester 
• 271578-70-2 4-[2-(tert-butyl-dimethyl-silanyloxymethyl)-3,4,6-trimethoxy-5-methyl-phenyl]-but-2-en-1-ol 
• 271578-67-7 2,2-Dimethyl-propionic acid (E)-4-(3-hydroxy-2-hydroxymethyl-4,6-dimethoxy-5-methyl-phenyl)-but-2-enyl ester 
• 271578-65-5 tert-butyl-[4-(2,4-dimethoxy-5-methoxymethoxy-3-methyl-phenyl)-but-2-enyloxy]-dimethyl-silane 
• 351379-98-1 2,2-Dimethyl-propionic acid (E)-4-(2-hydroxymethyl-3,4,6-trimethoxy-5-methyl-phenyl)-but-2-enyl ester 
• 351379-23-2 2,2-Dimethyl-propionic acid (E)-4-(5-hydroxy-2,4-dimethoxy-3-methyl-phenyl)-but-2-enyl ester 
• 271578-63-3 2-[4-(tert-butyl-dimethyl-silanyloxy)-but-2-enyloxy]-4-methoxy-3-methyl-benzaldehyde 
• 351380-00-2 2-[4-(tert-butyl-dimethyl-silanyloxy)-but-2-enyloxy]-4-methoxy-3-methyl-phenol 
• 54700-36-6 2-hydroxy-4-methoxy-3-methylbenzaldehyde 
• 24424-99-5 di-tert-butyl dicarbonate 
• 271578-73-5 {2-[(S)-2-Azido-2-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-ethyl]-3,5,6-trimethoxy-4-methyl-benzyloxy}-tert-butyl-dimethyl-silane 
• 351379-95-8 4-[4-(tert-butyl-dimethyl-silanyloxy)-but-2-enyl]-3-methoxy-6-methoxymethoxy-2-methyl-phenol 
• 271578-64-4 tert-butyl-[4-(3-methoxy-6-methoxymethoxy-2-methyl-phenoxy)-but-2-enyloxy]-dimethyl-silane 

Downstream Products

• 351380-22-8 {(1S,2S)-2,3-Dihydroxy-1-[2,4,5-trimethoxy-6-(4-methoxy-benzyloxymethyl)-3-methyl-benzyl]-propyl}-methyl-carbamic acid tert-butyl ester 
• 271578-76-8 {(S)-1-((S)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-2-[2,4,5-trimethoxy-6-(4-methoxy-benzyloxymethyl)-3-methyl-phenyl]-ethyl}-carbamic acid tert-butyl ester 
• 271578-77-9 2-(tert-butoxycarbonyl-methyl-amino)-3-[2,4,5-trimethoxy-6-(4-methoxy-benzyloxymethyl)-3-methyl-phenyl]-propionic acid 

Relevant academic research and scientific papers

Synthetic explorations in the saframycin-ecteinascidin series: Construction of major chiral subunits through catalytic asymmetric induction

The major subunits needed to reach the titled targets have been assembled by chemistry, which included p-Claisen rearrangement, asymmetric epoxidation and asymmetric dihydroxylation. (C) 2000 Elsevier Science Ltd.